Moffitt Cancer Center researchers find MK1775 active against sarcomas
Friday, December 2, 2011 - 17:30
in Health & Medicine
MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla. Their findings, recently appearing...